Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01VPR
|
||||
| Former ID |
DIB012786
|
||||
| Drug Name |
BBR-3438
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Gastric cancer [ICD9: 151; ICD10:C16] | Discontinued in Phase 2 | [1] | ||
| Company |
Roche Holding AG
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H24N6O2
|
||||
| Canonical SMILES |
c12c3c(c(=O)c4c2cncc4)c(ccc3n(n1)CCNCCO)NCCNC.Cl.Cl
|
||||
| CAS Number |
CAS 438244-41-8
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Human DNA | Target Info | Binder | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007244) | ||||
| REF 2 | A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts. Oncology. 2001;61(3):234-42. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.